(NOW) ServiceNow - Overview
Stock: Digital Workflows, Cloud Platform, IT Service Management, Security Operations, Workflow Automation
| Risk 5d forecast | |
|---|---|
| Volatility | 48.6% |
| Relative Tail Risk | -2.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.14 |
| Alpha | -64.21 |
| Character TTM | |
|---|---|
| Beta | 1.380 |
| Beta Downside | 0.910 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.03% |
| CAGR/Max DD | 0.12 |
EPS (Earnings per Share)
Revenue
Description: NOW ServiceNow February 28, 2026
ServiceNow, Inc. (NYSE: NOW) delivers a broad suite of cloud-based workflow solutions-including IT service management, security operations, HR, legal, and source-to-pay-across North America, EMEA, APAC and other international markets. Its platform unifies asset, risk, and operational technology management while offering low-code app development and AI-driven automation tools such as ServiceNow Impact and the RaptorDB database.
In FY 2024 the company posted record revenue of **$8.1 billion**, a **19% year-over-year increase**, driven by strong subscription growth that now represents roughly **92% of total revenue**. Non-GAAP operating margin expanded to **27%**, and the total contract value (TCV) of its annual recurring revenue (ARR) surpassed **$12.5 billion**, underscoring the stickiness of its enterprise customer base.
ServiceNow serves high-touch sectors-including government, financial services, healthcare, manufacturing, and telecom-through both direct sales and a global network of service-provider and resale partners. The broader systems-software market is being propelled by a **15% CAGR forecast for enterprise cloud spending** through 2027, with regulated industries accelerating digital-workflow adoption to meet compliance and efficiency mandates.
For a deeper dive into valuation metrics, you might explore ValueRay’s analysis.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.75b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 0.97 > 1.0 |
| NWC/Revenue: -4.23% < 20% (prev 7.55%; Δ -11.78% < -1%) |
| CFO/TA 0.21 > 3% & CFO 5.44b > Net Income 1.75b |
| Net Debt (-523.0m) to EBITDA (3.02b): -0.17 < 3 |
| Current Ratio: 0.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.05b) vs 12m ago 0.19% < -2% |
| Gross Margin: 77.53% > 18% (prev 0.79%; Δ 7674 % > 0.5%) |
| Asset Turnover: 57.21% > 50% (prev 53.89%; Δ 3.32% > 0%) |
| Interest Coverage Ratio: 99.09 > 6 (EBITDA TTM 3.02b / Interest Expense TTM 23.0m) |
Altman Z'' 1.60
| A: -0.02 (Total Current Assets 9.88b - Total Current Liabilities 10.44b) / Total Assets 26.04b |
| B: 0.20 (Retained Earnings 5.24b / Total Assets 26.04b) |
| C: 0.10 (EBIT TTM 2.28b / Avg Total Assets 23.21b) |
| D: 0.40 (Book Value of Equity 5.26b / Total Liabilities 13.07b) |
| Altman-Z'' Score: 1.60 = BB |
Beneish M -2.93
| DSRI: 0.97 (Receivables 2.63b/2.24b, Revenue 13.28b/10.98b) |
| GMI: 1.02 (GM 77.53% / 79.18%) |
| AQI: 1.17 (AQ_t 0.50 / AQ_t-1 0.43) |
| SGI: 1.21 (Revenue 13.28b / 10.98b) |
| TATA: -0.14 (NI 1.75b - CFO 5.44b) / TA 26.04b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
What is the price of NOW shares?
Over the past week, the price has changed by +3.59%, over one month by -18.05%, over three months by -33.52% and over the past year by -41.36%.
Is NOW a buy, sell or hold?
- StrongBuy: 31
- Buy: 10
- Hold: 5
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the NOW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 188.7 | 74.7% |
| Analysts Target Price | 188.7 | 74.7% |
NOW Fundamental Data Overview February 28, 2026
P/E Forward = 45.2489
P/S = 8.6856
P/B = 17.2762
P/EG = 1.7172
Revenue TTM = 13.28b USD
EBIT TTM = 2.28b USD
EBITDA TTM = 3.02b USD
Long Term Debt = 1.49b USD (from longTermDebt, last quarter)
Short Term Debt = 112.0m USD (from shortTermDebt, last quarter)
Debt = 3.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -523.0m USD (from netDebt column, last quarter)
Enterprise Value = 114.80b USD (115.33b + Debt 3.20b - CCE 3.73b)
Interest Coverage Ratio = 99.09 (Ebit TTM 2.28b / Interest Expense TTM 23.0m)
EV/FCF = 25.09x (Enterprise Value 114.80b / FCF TTM 4.58b)
FCF Yield = 3.99% (FCF TTM 4.58b / Enterprise Value 114.80b)
FCF Margin = 34.46% (FCF TTM 4.58b / Revenue TTM 13.28b)
Net Margin = 13.16% (Net Income TTM 1.75b / Revenue TTM 13.28b)
Gross Margin = 77.53% ((Revenue TTM 13.28b - Cost of Revenue TTM 2.98b) / Revenue TTM)
Gross Margin QoQ = 76.63% (prev 77.28%)
Tobins Q-Ratio = 4.41 (Enterprise Value 114.80b / Total Assets 26.04b)
Interest Expense / Debt = 0.16% (Interest Expense 5.00m / Debt 3.20b)
Taxrate = 25.88% (140.0m / 541.0m)
NOPAT = 1.69b (EBIT 2.28b * (1 - 25.88%))
Current Ratio = 0.95 (Total Current Assets 9.88b / Total Current Liabilities 10.44b)
Debt / Equity = 0.25 (Debt 3.20b / totalStockholderEquity, last quarter 12.96b)
Debt / EBITDA = -0.17 (Net Debt -523.0m / EBITDA 3.02b)
Debt / FCF = -0.11 (Net Debt -523.0m / FCF TTM 4.58b)
Total Stockholder Equity = 11.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.53% (Net Income 1.75b / Total Assets 26.04b)
RoE = 15.42% (Net Income TTM 1.75b / Total Stockholder Equity 11.33b)
RoCE = 17.77% (EBIT 2.28b / Capital Employed (Equity 11.33b + L.T.Debt 1.49b))
RoIC = 13.17% (NOPAT 1.69b / Invested Capital 12.82b)
WACC = 10.71% (E(115.33b)/V(118.53b) * Re(11.0%) + D(3.20b)/V(118.53b) * Rd(0.16%) * (1-Tc(0.26)))
Discount Rate = 11.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.58%
[DCF] Terminal Value 72.99% ; FCFF base≈4.10b ; Y1≈5.06b ; Y5≈8.61b
[DCF] Fair Price = 89.94 (EV 93.55b - Net Debt -523.0m = Equity 94.07b / Shares 1.05b; r=10.71% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 90.26 | EPS CAGR: 29.40% | SUE: 0.80 | # QB: 0
Revenue Correlation: 99.80 | Revenue CAGR: 21.44% | SUE: 1.16 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.97 | Chg7d=+0.001 | Chg30d=+0.017 | Revisions Net=+20 | Analysts=36
EPS current Year (2026-12-31): EPS=4.16 | Chg7d=+0.003 | Chg30d=+0.088 | Revisions Net=+32 | Growth EPS=+18.6% | Growth Revenue=+20.4%
EPS next Year (2027-12-31): EPS=5.01 | Chg7d=+0.003 | Chg30d=+0.125 | Revisions Net=+20 | Growth EPS=+20.4% | Growth Revenue=+18.5%
[Analyst] Revisions Ratio: +0.77 (23 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.5% (Discount Rate 11.0% - Earnings Yield 1.5%)
[Growth] Growth Spread = +11.9% (Analyst 21.3% - Implied 9.5%)